...
机译:Safety, tolerability, and pharmacokinetics of the novel pan-phosphodiesterase inhibitor ZSP1601 in healthy subjects: a double-blinded, placebo-controlled first-in-human single-dose and multiple-dose escalation and food effect study
Jilin Univ, Hosp 1, Phase I Clin Trial Unit, Changchun 130021, Peoples R China;
Jilin Med Prod Adm, Changchun, Peoples R China;
Guangdong Raynovent Biotech Co Ltd, Med Affairs, Shenzhen, Peoples R ChinaGuangdong Zhongsheng Pharmaceut Co Ltd, Med Affairs, Dongguan, Peoples R China;
Food effect; pharmacokinetics; safety; tolerability; ZSP1601;